Stem cell transplantation approaches offer for the first time the opportunity to design therapeutic approaches for multiple sclerosis (MS) with curative intent. Here we discuss key observations and questions emerging from clinical trials of hematopoietic stem cell transplantation for MS and from studies of myelin/neural repair in experimental models of demyelinating disorders
The availability of multiple disease-modifying medications with regulatory approval to treat multipl...
Multiple sclerosis (MS) is an inflammatory and neurodegenerative autoimmune disease of the central n...
Hematopoietic stem cell transplantation (HSCT) was proposed as a treatment for multiple sclerosis (M...
Multiple sclerosis (MS) is a chronic inflammatory, autoimmune, and neurodegenerative disease of the ...
Multiple sclerosis (MS) is a chronic inflammatory, autoimmune, and neurodegenerative disease of the ...
Hematopoietic stem cell transplantation (HSCT) is a treatment paradigm that has long been utilized f...
Hematopoietic stem cell transplantation (HSCT) is a treatment paradigm that has long been utilized f...
Multiple Sclerosis is an inflammatory disease of the central nervous system in which T cells experie...
This article provides an overview of the current knowledge relating to the potential use of transpla...
Multiple Sclerosis (MS) is an inflammatory demyelinating neurodegenerative disorder of the brain and...
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS)...
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS)...
This article provides an overview of the current knowledge relating to the potential use of transpla...
Stem cells offer the potential for regeneration of lost tissue in neurological disease, including mu...
The recent advances in our understanding of stem cell biology, the availability of innovative techni...
The availability of multiple disease-modifying medications with regulatory approval to treat multipl...
Multiple sclerosis (MS) is an inflammatory and neurodegenerative autoimmune disease of the central n...
Hematopoietic stem cell transplantation (HSCT) was proposed as a treatment for multiple sclerosis (M...
Multiple sclerosis (MS) is a chronic inflammatory, autoimmune, and neurodegenerative disease of the ...
Multiple sclerosis (MS) is a chronic inflammatory, autoimmune, and neurodegenerative disease of the ...
Hematopoietic stem cell transplantation (HSCT) is a treatment paradigm that has long been utilized f...
Hematopoietic stem cell transplantation (HSCT) is a treatment paradigm that has long been utilized f...
Multiple Sclerosis is an inflammatory disease of the central nervous system in which T cells experie...
This article provides an overview of the current knowledge relating to the potential use of transpla...
Multiple Sclerosis (MS) is an inflammatory demyelinating neurodegenerative disorder of the brain and...
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS)...
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS)...
This article provides an overview of the current knowledge relating to the potential use of transpla...
Stem cells offer the potential for regeneration of lost tissue in neurological disease, including mu...
The recent advances in our understanding of stem cell biology, the availability of innovative techni...
The availability of multiple disease-modifying medications with regulatory approval to treat multipl...
Multiple sclerosis (MS) is an inflammatory and neurodegenerative autoimmune disease of the central n...
Hematopoietic stem cell transplantation (HSCT) was proposed as a treatment for multiple sclerosis (M...